Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'formula' OR with Authors including 'formula' OR with Abstract including 'formula' OR with Keywords including 'formula'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Burroughs W Letter From A Master Addict To Dangerous Drugs British Journal of A... 1956
Cerletti A Teonanacatl und Psilocybin Deutsche Medizinishe... 1959
Cohen S The therapeutic potential of LSD-25 A Pharmacologic Appr... 1959
Hofmann A, Heim R, Brack ... Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen... Helv. chim. Acta 1959
Associated Press Kids Shooting Peanut Butter San Francisco Chroni... 1969
Fisher G, Martin AJ The Psychotherapeutic Use Of Psychodysleptic Drugs Voices: The Art and ... 1970
Winkelhake JL, Voss W Jr,... Comparative Inhibitory Action of D- and L-Tryptophan on the Effect of ... Molec Pharmacol. 1974
Reichelt J Analytical Studies Of Ergot Alkaloids And Their Derivatives. IV. Quick... Cs. Farm. 1976
Schild HO L'ergot de seigle: des conceptions de dale aux récepteurs J.Pharmacol. 1979
[No authors listed] The 1977 Street Drug Analysis results: PharmChem Research Foundation Clin Toxicol 1979
Shulgin AT The background and chemistry of MDMA J Psychoactive Drugs 1986
Koreeda M, Brown L, Vald The Absolute Stereochemistry of Salvinorins The Chemical Society... 1990
Glennon RA Phenylalkylamine stimulants, hallucinogens, and designer drugs NIDA Res Monogr 1991
Tsarong TJ Tibetan Psychopharmacology Integration 1991
Riedlinger, FLS TJ Existential Transactions at Harvard: Timothy Leary's Humanistic Psycho... Journal of Humanisti... 1993
Westkaemper RB, Glennon R... Molecular Modeling of the Interaction of LSD and Other Hallucinogens W... NIDA Research Monogr... 1994
Young R, Dukat M, Malmusi... Stimulus properties of PMMA: effect of optical isomers and conformatio... Pharmacol Biochem Be... 1999
Glennon RA Arylalkylamine drugs of abuse: an overview of drug discrimination stud... Pharmacol Biochem Be... 1999
Rothman RB, Partilla JS, ... Neurochemical neutralization of methamphetamine with high-affinity non... Synapse 2000
Smith KM, Larive LL, Roma... Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hyd... Am J Health Syst Pha... 2002
De Feo V. Ethnomedical Field Study in Northern Peruvian Andes with Particular Re... Journal of Ethnophar... 2003
Liu D, Chen XY, Zhang YF,... [Determination of dextrorphan in human plasma and pharmacokinetic stud... Yao Xue Xue Bao 2004
Pizarro N, Farre M, Pujad... Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its m... Drug Metab Dispos 2004
Boyer EW Dextromethorphan abuse Pediatr Emerg Care 2004
Biederman J, Swanson JM, ... Efficacy and safety of modafinil film-coated tablets in children and a... Pediatrics 2005
Cone EJ Ephemeral profiles of prescription drug and formulation tampering: Evo... Drug Alcohol Depend 2006
Rasmussen N Making the first anti-depressant: amphetamine in American medicine, 19... J Hist Med Allied Sc... 2006
Tallarida RJ An overview of drug combination analysis with isobolograms J Pharmacol Exp Ther 2006
Bryner JK, Wang UK, Hui J... Dextromethorphan abuse in adolescence: an increasing trend: 1999-2004 Arch Pediatr Adolesc... 2006
Addy P Facilitating transpersonal experiences with dextromethorphan: potentia... Journal of Transpers... 2007
Ashton CH, Moore PB, Sum... Regulation of synthetic cannabinoids Lancet 2009
Tadini KA, Campos PM In vivo skin effects of a dimethylaminoethanol (DMAE) based formulatio... Pharmazie 2009
O'Connor EC, Mead AN Tramadol acts as a weak reinforcer in the rat self-administration mode... Pharmacol Biochem Be... 2010
Krupitsky E, Nunes EV, Li... Injectable extended-release naltrexone for opioid dependence: a double... Lancet 2011
Uchiyama N, Kikura-Hanaji... Identification of a Novel Cannabimimetic Phenylacetylindole, Cannabipi... Chem Pharm Bull (Tok... 2011
Sumnall HR, Evans-Brown M... Social, policy, and public health perspectives on new psychoactive sub... Drug Test Anal 2011
Goli V, Webster LR, Lamso... Effects of concurrent intravenous morphine sulfate and naltrexone hydr... Harm Reduct J 2012
Zuba D, Seku?a K Analytical characterization of three hallucinogenic N-(2-methoxy)benzy... Drug Test Anal 2012
Zuba D, Sekuła K, Bu... 25C-NBOMe--new potent hallucinogenic substance identified on the drug ... Forensic Sci Int 2013
Boyle KL, Rosenbaum CD Oxymorphone insufflation associated with acute sensorineural hearing l... J Med Toxicol 2013
Liput DJ, Hammell DC, Sti... Transdermal delivery of cannabidiol attenuates binge alcohol-induced n... Pharmacol Biochem Be... 2013
Seely KA, Patton AL, Mora... Forensic investigation of K2, Spice, and bath salt commercial preparat... Forensic Sci Int 2013
Schoenfuss HL, Furlong ET... Complex mixtures, complex responses: Assessing pharmaceutical mixtures... Environ Toxicol Chem 2015
Dierksen J, Gonsoulin M, ... Poor Man's Methadone: A Case Report of Loperamide Toxicity Am J Forensic Med Pa... 2015
Katselou M, Papoutsis I, ... Old opioids, new concerns: the case of acetylfentanyl Forensic Toxicol 2016
Csete J, Kamarulzaman A, ... Public health and international drug policy Lancet 2016
Lee JD, Friedmann PD, Kin... Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Just... N Engl J Med 2016
Harned M, Sloan P Safety concerns with long-term opioid use Expert Opin Drug Saf 2016
Kimergĺrd A, Deluca P, Hi... How Resistant to Tampering are Codeine Containing Analgesics on the Ma... Pain Ther 2016
Trabsa A, Monteagudo E, M... What are sweet dreams made of? Analysis of psychoactive substances int... European Psychiatry 2017
Aldridge J, Stevens A, Ba... Will growth in cryptomarket drug buying increase the harms of illicit ... Addiction 2017
Iwersen-Bergmann S, Lehma... Mass poisoning with NPS: 2C-E and Bromo-DragonFly Int J Legal Med 2018